Holen Sie sich die Stockscreener-App
0.6295
5.78%
-0.0386
Handel nachbörslich:
.63
0.0005
+0.08%
Schlusskurs vom Vortag:
$0.6681
Offen:
$0.66
24-Stunden-Volumen:
292.65K
Relative Volume:
0.85
Marktkapitalisierung:
$26.30M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-74.56M
KGV:
-0.3437
EPS:
-1.8316
Netto-Cashflow:
$-60.27M
1W Leistung:
+1.84%
1M Leistung:
+11.44%
6M Leistung:
+98.58%
1J Leistung:
-38.28%
1-Tages-Spanne:
$0.6191
$0.672
1-Wochen-Bereich:
$0.60
$0.72
52-Wochen-Spanne:
$0.2201
$1.2401
Rallybio Corp Stock (RLYB) Company Profile
Firmenname
Rallybio Corp
Sektor
Branche
Telefon
203- 859-3820
Adresse
234 CHURCH STREET, NEW HAVEN
Vergleichen Sie RLYB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RLYB
Rallybio Corp
|
0.6295 | 27.92M | 0 | -74.56M | -60.27M | -1.8316 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rallybio Corp Stock (RLYB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-09 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-05-15 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-02-07 | Herabstufung | Jefferies | Buy → Hold |
| 2023-04-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-04-10 | Eingeleitet | Wedbush | Outperform |
| 2022-12-09 | Eingeleitet | JP Morgan | Overweight |
| 2022-02-22 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-08-23 | Eingeleitet | Cowen | Outperform |
| 2021-08-23 | Eingeleitet | Evercore ISI | Outperform |
| 2021-08-23 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Rallybio Corp Aktie (RLYB) Neueste Nachrichten
Can Rallybio Corporation stock hit record highs againEntry Point & Free AI Powered Buy and Sell Recommendations - newser.com
Why retail investors favor Rallybio Corporation stockMarket Performance Summary & Verified Momentum Stock Alerts - newser.com
Will Rallybio Corporation continue its uptrendJuly 2025 Summary & Proven Capital Preservation Tips - newser.com
How to monitor Rallybio Corporation with trend dashboardsJuly 2025 Momentum & Low Risk High Reward Trade Ideas - newser.com
Is Rallybio Corporation trending in predictive chart modelsQuarterly Market Summary & Daily Stock Trend Watchlist - newser.com
How Rallybio Corporation stock performs in rising dollar environmentJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com
Why Rallybio Corporation stock remains on buy listsBull Run & Verified Trade Idea Suggestions - newser.com
Technical signs of recovery in Rallybio CorporationJuly 2025 Price Swings & Verified Momentum Stock Watchlist - newser.com
How to build a custom watchlist for Rallybio CorporationMarket Trend Report & Weekly Stock Breakout Alerts - newser.com
Will Rallybio Corporation stock beat EPS estimatesGap Up & Stepwise Entry and Exit Trade Signals - newser.com
Is Rallybio Corporation stock reversal real or fakeWall Street Watch & Capital Efficient Trade Techniques - newser.com
Is Rallybio Corporation a candidate for recovery playJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - newser.com
Using Ichimoku Cloud for Rallybio Corporation technicalsMarket Activity Recap & Precise Entry and Exit Recommendations - newser.com
Rallybio’s RLYB116 Study: A Potential Game-Changer in Hematologic and Autoimmune Disease Treatment - TipRanks
Is Rallybio Corporation stock undervalued vs historical averagesMarket Performance Recap & Fast Entry and Exit Trade Plans - Fundação Cultural do Pará
Why Rallybio Corporation stock attracts global investors2025 Year in Review & Stepwise Entry and Exit Trade Signals - fcp.pa.gov.br
Finanzdaten der Rallybio Corp-Aktie (RLYB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):